Tradestie Institutional Equity Comparison Engine

MTNB vs VTGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VTGN Overall Edge

VTGN Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vistagen Therapeutics, Inc. Common Stock (VTGN) driven by superior Growth & Margin, Options & Structure while MTNB counters with relative strength in Momentum & Technical. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus VTGN at N/M Forward P/E and -2543.1% operating margin (-46.5% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VTGN sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MTNB N/M vs VTGN N/M Fwd P/E
Growth & Margin Winner VTGN
Op Margin 0.0% vs -2543.1% ยท YoY -100.0% vs -46.5%
Momentum & Technical Winner MTNB
1Y -31.4% vs -96.0% ยท 52W Pos 22% vs 0%
Options & Structure Winner VTGN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (71st %ile IV)
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
VTGN NASDAQ
Vistagen Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.19
-6.47% 1D
Market Cap $9.0M
1M Return -3.62%
1Y Return -95.97%
Forward P/E N/M
Unified AI Score
42.3 / 100 HOLD
Tech 20.0 Fund 52.0 Flow 69.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTNB -31.35% VTGN -95.97% Spread: +64.62 pp (MTNB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MTNB Revenue VTGN Revenue MTNB Op. Margin VTGN Op. Margin Margin Edge
FY2019 $0M N/A -21067.4% N/A MTNB
FY2020 $0M N/A -15288.4% N/A MTNB
FY2021 $0M $0M -74954.5% -1646.1% VTGN
FY2022 $0M $0M -771.3% -4308.3% MTNB
FY2023 $0M N/A -2168.4% N/A MTNB
FY2024 N/A $0M N/A -3103.5% VTGN
FY2025 N/A $0M N/A -11517.1% VTGN
FY2026 N/A $0M N/A -5683.7% VTGN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTNB (3) vs VTGN (3)
Institutional Metric MTNB VTGN Criterion Row Winner
Market Capitalization Scale $979,904 $9.0M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% -46.5% Higher Growth VTGN
Operating Margin (TTM) Profitability 0.0% -2543.1% Higher Margin MTNB
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -147.5% -144.9% Higher ROE VTGN
52-Week Range Position Momentum 22% ($0โ€“$3) 0% ($0โ€“$5) Stronger Trend MTNB
Beta / 30D Volatility Risk Regime -7.20ฮฒ ยท 147% Vol 1.23ฮฒ ยท 80% Vol Lower Realized Risk VTGN
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 42.3 / 100 (HOLD) Higher Composite MTNB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTNB vs VTGN Buy Guide
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VTGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 71st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VTGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTNB nor VTGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.